Jae-Weon Kim
Overview
Explore the profile of Jae-Weon Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
2332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park J, Joung J, Lim M, Lee J, Kim B, Kim J, et al.
Clin Cancer Res
. 2025 Mar;
PMID: 40043003
Purpose: This open-label, investigator-initiated, phase II study was conducted to evaluate the safety, survival and neoadjuvant outcomes of NAC combined with dual immune checkpoint inhibitors in advanced-stage EOC. Patients And...
2.
Wang P, Yang S, Kim J
Taiwan J Obstet Gynecol
. 2025 Jan;
64(1):1-3.
PMID: 39794012
No abstract available.
3.
Scambia G, Villalobos Valencia R, Colombo N, Cibula D, Leath 3rd C, Bidzinski M, et al.
J Clin Oncol
. 2024 Dec;
:JCO2400933.
PMID: 39668137
Olaparib treatment significantly improved objective response rate (primary end point) and progression-free survival versus nonplatinum chemotherapy in patients with BRCA-mutated platinum-sensitive relapsed ovarian cancer in the open-label phase III SOLO3...
4.
Kim J, Kim S, Park E, Ha H, Kim J, Coleman R, et al.
Gynecol Oncol
. 2024 Nov;
179:24-32.
PMID: 39491079
Background: Current treatment strategies for primary epithelial ovarian cancer (EOC) have significantly evolved, and the value of complete cytoreduction has not yet been reassessed. The study aimed to investigate the...
5.
Min K, Ouh Y, Bae S, Ji Y, Lee J, Kim J, et al.
Vaccines (Basel)
. 2024 Oct;
12(10).
PMID: 39460277
Given the rising incidence of human papillomavirus (HPV)-related diseases, including cervical, penile, and oropharyngeal cancers, particularly among men, the implementation of comprehensive HPV vaccination strategies is necessary in South Korea....
6.
Kwon J, McTaggart-Cowan H, Ferguson S, Samouelian V, Lambaudie E, Guyon F, et al.
J Gynecol Oncol
. 2024 Oct;
35(6):e117.
PMID: 39453395
Objective: SHAPE (Simple Hysterectomy And PElvic node assessment) was an international phase III trial demonstrating that simple hysterectomy was non-inferior to radical hysterectomy for pelvic recurrence risk, but superior for...
7.
Kim S, Kim J, Park E, Kim E, Choi E, Kim J, et al.
Int J Gynecol Cancer
. 2024 Oct;
PMID: 39448085
Objective: This multicenter retrospective cohort study aimed to compare survival outcomes and adverse events between early and late initiation of niraparib maintenance therapy in patients with newly diagnosed advanced ovarian...
8.
Min K, Kim N, Song J, Choi M, Lee S, Lee K, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39410040
The Korean Gynecologic Oncology Group (KGOG) was established in 2002 and is the only organization in Korea conducting multi-center clinical trials for gynecologic cancers. Since its re-establishment as a non-profit...
9.
Ferguson S, Brotto L, Kwon J, Samouelian V, Ferron G, Maulard A, et al.
J Clin Oncol
. 2024 Oct;
43(2):167-179.
PMID: 39353164
Purpose: Simple hysterectomy and pelvic node assessment (SHAPE) is a phase III randomized trial (ClinicalTrials.gov identifier: NCT01658930) reporting noninferiority of simple compared with radical hysterectomy for oncologic outcomes in low-risk...
10.
Ray-Coquard I, Casali P, Croce S, Fennessy F, Fischerova D, Jones R, et al.
Int J Gynecol Cancer
. 2024 Sep;
34(10):1499-1521.
PMID: 39322612
No abstract available.